AbbVie Inflanefran Forte eye drops

Inflanefran Forte is a pharmaceutical eye drop suspension containing prednisolone acetate, used primarily to treat non-infectious eye inflammation. The brand is associated with AbbVie, a leading global biopharmaceutical company. Historically, many of these ophthalmic products were part of Allergan's portfolio before its acquisition by AbbVie.

Manufacturing of AbbVie's pharmaceutical products occurs across a global network of facilities, including significant sites in the United States, Ireland, and Germany to serve the European market. AbbVie was founded in 2013 as a spin-off from Abbott Laboratories, inheriting a legacy of medical innovation that dates back to the late 19th century. Today, it stands as one of the largest independent pharmaceutical companies in the world, focused on specialized medicines and healthcare solutions.